Report Categories
View AllRecent Articles
View All
STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges
Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges
UFCS Q1 2026 Earnings EPS Surges Past Estimates by 37 as Stock Declines
BEEM Q1 2026 Earnings EPS Misses Estimates as Beam Global Reports WiderThanExpected Loss
Quince Therapeutics Inc QNCX Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Over 200